TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
IMNM

Immunome Inc

Healthcare · Biotechnology

25.80$ +2.7% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow IMNM
Line item 2018 2019 2020 2021 2022 2023 2024 2025
-432.9% -54.0% -1,225.5% -2,750.6%
9.5% 5.2% 23.2% 42.6%
80.5% 44.4% 174.2% 370.1%
80.5%
33.8% 85.6% 164.5% -219.4%
3.7% 5.9% 591.8% 139.5%
-3.7% -217.5% -940.9% 876.0%
0.5%
7.4%
0.5% 830.4% 2,660.4% 9,225.7%
-436.2% 559.0% 494.1% 7,351.1%
-436.7% -59.9% -1,817.3% -2,890.1%

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?